Thomas Elebring

Title: The Innovative Contributions of Thomas Elebring

Introduction

Thomas Elebring is a notable inventor based in Pixbo, Sweden. He has made significant contributions to the field of chemistry, particularly in the development of novel compounds. With a total of 4 patents to his name, Elebring's work has implications in pharmaceutical applications.

Latest Patents

Among his latest patents are the "Aminopropylphosphinic acids - Intermediates used in the preparation of compounds of formula I, or a stereoisomer thereof, or a pharmaceutically acceptable form of either selected from the group consisting of a salt, a solvate and a combination thereof, with the exception of i) the racemate of (3-amino-2-hydroxypropyl)phosphinic acid; and ii) (2R/S,3R)-(3-amino-2-hydroxybutyl)phosphinic acid." This patent highlights his focus on innovative chemical compounds that can be utilized in various pharmaceutical formulations. Additionally, he has developed "Aminopropylphosphinic acids - Novel compounds of formula I," further showcasing his expertise in this specialized area.

Career Highlights

Throughout his career, Elebring has been associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to contribute to significant advancements in drug development and chemical research. His innovative mindset and dedication to his field have made him a valuable asset to the company.

Collaborations

Thomas Elebring has collaborated with esteemed colleagues such as Peter Guzzo and Marianne Swanson. These partnerships have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking solutions in the pharmaceutical industry.

Conclusion

In summary, Thomas Elebring is a distinguished inventor whose work in the field of chemistry has led to the development of important pharmaceutical compounds. His contributions, particularly through his patents, reflect his commitment to innovation and excellence in research.